<?xml version='1.0' encoding='utf-8'?>
<document id="26991491"><sentence text="Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs."><entity charOffset="18-31" id="DDI-PubMed.26991491.s1.e0" text="carbamazepine" /><entity charOffset="36-63" id="DDI-PubMed.26991491.s1.e1" text="carbamazepine-10,11-epoxide" /><entity charOffset="145-158" id="DDI-PubMed.26991491.s1.e2" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.26991491.s1.e0" e2="DDI-PubMed.26991491.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s1.e0" e2="DDI-PubMed.26991491.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26991491.s1.e0" e2="DDI-PubMed.26991491.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26991491.s1.e1" e2="DDI-PubMed.26991491.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26991491.s1.e1" e2="DDI-PubMed.26991491.s1.e2" /></sentence><sentence text="Carbamazepine is one of the three most frequently prescribed antiepileptic drugs in pregnancy"><entity charOffset="0-13" id="DDI-PubMed.26991491.s2.e0" text="Carbamazepine" /></sentence><sentence text=" However, data relating to both carbamazepine and carbamazepine-10,11-epoxide transplacental passage remain sparse"><entity charOffset="32-45" id="DDI-PubMed.26991491.s3.e0" text="carbamazepine" /><entity charOffset="50-77" id="DDI-PubMed.26991491.s3.e1" text="carbamazepine-10,11-epoxide" /><pair ddi="false" e1="DDI-PubMed.26991491.s3.e0" e2="DDI-PubMed.26991491.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s3.e0" e2="DDI-PubMed.26991491.s3.e1" /></sentence><sentence text="" /><sentence text="We have analysed in a cohort of 114 women carbamazepine and carbamazepine-10,11-epoxide levels in maternal and umbilical cord serum at birth during 25 years retrospectively"><entity charOffset="42-55" id="DDI-PubMed.26991491.s5.e0" text="carbamazepine" /><entity charOffset="60-87" id="DDI-PubMed.26991491.s5.e1" text="carbamazepine-10,11-epoxide" /><pair ddi="false" e1="DDI-PubMed.26991491.s5.e0" e2="DDI-PubMed.26991491.s5.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s5.e0" e2="DDI-PubMed.26991491.s5.e1" /></sentence><sentence text=" The carbamazepine maternal apparent oral clearance, ratio of the umbilical cord/maternal level and ratio of the carbamazepine-10,11-epoxide/carbamazepine ratio were estimated"><entity charOffset="5-18" id="DDI-PubMed.26991491.s6.e0" text="carbamazepine" /><entity charOffset="113-140" id="DDI-PubMed.26991491.s6.e1" text="carbamazepine-10,11-epoxide" /><entity charOffset="141-154" id="DDI-PubMed.26991491.s6.e2" text="carbamazepine" /><pair ddi="false" e1="DDI-PubMed.26991491.s6.e0" e2="DDI-PubMed.26991491.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s6.e0" e2="DDI-PubMed.26991491.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26991491.s6.e0" e2="DDI-PubMed.26991491.s6.e2" /><pair ddi="false" e1="DDI-PubMed.26991491.s6.e1" e2="DDI-PubMed.26991491.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26991491.s6.e1" e2="DDI-PubMed.26991491.s6.e2" /></sentence><sentence text=" The influence of co-medication with valproic acid or enzyme-inducing antiepileptic drugs was evaluated"><entity charOffset="37-50" id="DDI-PubMed.26991491.s7.e0" text="valproic acid" /></sentence><sentence text="" /><sentence text="The maternal carbamazepine levels varied from 0"><entity charOffset="13-26" id="DDI-PubMed.26991491.s9.e0" text="carbamazepine" /></sentence><sentence text="6 to 11" /><sentence text="8mg/L (carbamazepine-10,11-epoxide 0" /><sentence text="1-2" /><sentence text="5mg/L) and in umbilical cord between 0" /><sentence text="1 and 10" /><sentence text="5mg/L (carbamazepine-10,11-epoxide 0"><entity charOffset="7-34" id="DDI-PubMed.26991491.s15.e0" text="carbamazepine-10,11-epoxide" /></sentence><sentence text="1-2" /><sentence text="2mg/L)" /><sentence text=" The ratio the of umbilical cord/maternal level of carbamazepine ranged from 0"><entity charOffset="51-64" id="DDI-PubMed.26991491.s18.e0" text="carbamazepine" /></sentence><sentence text="03 to 2" /><sentence text="23 (median 0" /><sentence text="80) and of carbamazepine-10,11-epoxide between 0"><entity charOffset="11-38" id="DDI-PubMed.26991491.s21.e0" text="carbamazepine-10,11-epoxide" /></sentence><sentence text="17 and 2" /><sentence text="00 (median 0" /><sentence text="83)" /><sentence text=" Concomitant administration with enzyme inducers significantly increased the maternal apparent oral clearance by approximately 50% and co-administration with valproic acid approximately by 70%"><entity charOffset="158-171" id="DDI-PubMed.26991491.s25.e0" text="valproic acid" /></sentence><sentence text=" Combination with valproic acid significantly increased the rate of carbamazepine-10,11-epoxide to the parent drug both in maternal serum (by approximately 80%) and in umbilical cord (by 100%)"><entity charOffset="18-31" id="DDI-PubMed.26991491.s26.e0" text="valproic acid" /><entity charOffset="68-95" id="DDI-PubMed.26991491.s26.e1" text="carbamazepine-10,11-epoxide" /><pair ddi="false" e1="DDI-PubMed.26991491.s26.e0" e2="DDI-PubMed.26991491.s26.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s26.e0" e2="DDI-PubMed.26991491.s26.e1" /></sentence><sentence text="" /><sentence text="The data showed the wide interindividual variability of the ratio of the umbilical cord/maternal level of both carbamazepine and carbamazepine-10,11-epoxide"><entity charOffset="111-124" id="DDI-PubMed.26991491.s28.e0" text="carbamazepine" /><entity charOffset="129-156" id="DDI-PubMed.26991491.s28.e1" text="carbamazepine-10,11-epoxide" /><pair ddi="false" e1="DDI-PubMed.26991491.s28.e0" e2="DDI-PubMed.26991491.s28.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s28.e0" e2="DDI-PubMed.26991491.s28.e1" /></sentence><sentence text=" It is the first study showing the significant increase of the ratio of umbilical cord/maternal level of carbamazepine-10,11-epoxide and carbamazepine-10,11-epoxide/carbamazepine ratio not only in maternal serum but also in umbilical cord in addition of valproic acid"><entity charOffset="105-132" id="DDI-PubMed.26991491.s29.e0" text="carbamazepine-10,11-epoxide" /><entity charOffset="137-164" id="DDI-PubMed.26991491.s29.e1" text="carbamazepine-10,11-epoxide" /><entity charOffset="165-178" id="DDI-PubMed.26991491.s29.e2" text="carbamazepine" /><entity charOffset="254-267" id="DDI-PubMed.26991491.s29.e3" text="valproic acid" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e0" e2="DDI-PubMed.26991491.s29.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e0" e2="DDI-PubMed.26991491.s29.e1" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e0" e2="DDI-PubMed.26991491.s29.e2" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e0" e2="DDI-PubMed.26991491.s29.e3" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e1" e2="DDI-PubMed.26991491.s29.e1" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e1" e2="DDI-PubMed.26991491.s29.e2" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e1" e2="DDI-PubMed.26991491.s29.e3" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e2" e2="DDI-PubMed.26991491.s29.e2" /><pair ddi="false" e1="DDI-PubMed.26991491.s29.e2" e2="DDI-PubMed.26991491.s29.e3" /></sentence><sentence text=" The present study demonstrates that a concomitant administration of enzyme-inducing antiepileptics and valproic acid increases the maternal apparent oral clearance of carbamazepine significantly"><entity charOffset="104-117" id="DDI-PubMed.26991491.s30.e0" text="valproic acid" /><entity charOffset="168-181" id="DDI-PubMed.26991491.s30.e1" text="carbamazepine" /><pair ddi="false" e1="DDI-PubMed.26991491.s30.e0" e2="DDI-PubMed.26991491.s30.e0" /><pair ddi="false" e1="DDI-PubMed.26991491.s30.e0" e2="DDI-PubMed.26991491.s30.e1" /></sentence><sentence text="" /></document>